Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazen Almasry

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Crohn'S & Colitis 360|October 30, 2023
Providing Pneumococcal Vaccines Reduces the Risk of Serious Infections From Pneumococcal Pneumonia. We Should Consider a Simplified Immunization ScheduleMazen Almasry, Freddy Caldera
Digestive Diseases and Sciences|April 6, 2023
Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel DiseaseMazen Almasry, Freddy Caldera
Cureus|December 16, 2021
Dasatinib-Induced Nephrotic Syndrome: A Case ReportAhmed ElShaer, Mazen Almasry, Maher Alawar, et al.
Mededportal : the Journal of Teaching and Learning Resources|February 23, 2026
Development and Implementation of an OSCE for Formative Assessment of Core Clinical Skills in Internal Medicine InternsAlexandra Wick, Samantha Murray-Bainer, Jessica Tischendorf, et al.
Crohn'S & Colitis 360|April 24, 2026
Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person careMazen Almasry, Trevor L Schell, Luke Richard, et al.
Inflammatory Bowel Diseases|April 18, 2023
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel DiseaseTrevor L Schell, Oscar Ramirez, Mazen Almasry, et al.
Inflammatory Bowel Diseases|February 14, 2023
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel DiseaseFreddy Caldera, Luke Richard, Mazen Almasry, et al.
International Journal of Medical Education|August 18, 2017
Perceptions of preclinical medical students towards extracurricular activitiesMazen Almasry, Zeina Kayali, Rakan Alsaad, et al.
Therapeutic Advances in Gastroenterology|January 13, 2025
Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysisWassel Sannaa, Mazen Almasry, Mustafa Peedikayil, et al.
Digestive Diseases and Sciences|March 25, 2023
High Uptake of Three COVID-19 Vaccine Doses Among Liver Transplant RecipientsTrevor L Schell, Miguel A Mailig, Mazen Almasry, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Crohn'S & Colitis 360|October 30, 2023
Providing Pneumococcal Vaccines Reduces the Risk of Serious Infections From Pneumococcal Pneumonia. We Should Consider a Simplified Immunization ScheduleMazen Almasry, Freddy Caldera
Digestive Diseases and Sciences|April 6, 2023
Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel DiseaseMazen Almasry, Freddy Caldera
Cureus|December 16, 2021
Dasatinib-Induced Nephrotic Syndrome: A Case ReportAhmed ElShaer, Mazen Almasry, Maher Alawar, et al.
Mededportal : the Journal of Teaching and Learning Resources|February 23, 2026
Development and Implementation of an OSCE for Formative Assessment of Core Clinical Skills in Internal Medicine InternsAlexandra Wick, Samantha Murray-Bainer, Jessica Tischendorf, et al.
Crohn'S & Colitis 360|April 24, 2026
Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person careMazen Almasry, Trevor L Schell, Luke Richard, et al.
Inflammatory Bowel Diseases|April 18, 2023
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel DiseaseTrevor L Schell, Oscar Ramirez, Mazen Almasry, et al.
Inflammatory Bowel Diseases|February 14, 2023
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel DiseaseFreddy Caldera, Luke Richard, Mazen Almasry, et al.
International Journal of Medical Education|August 18, 2017
Perceptions of preclinical medical students towards extracurricular activitiesMazen Almasry, Zeina Kayali, Rakan Alsaad, et al.
Therapeutic Advances in Gastroenterology|January 13, 2025
Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysisWassel Sannaa, Mazen Almasry, Mustafa Peedikayil, et al.
Digestive Diseases and Sciences|March 25, 2023
High Uptake of Three COVID-19 Vaccine Doses Among Liver Transplant RecipientsTrevor L Schell, Miguel A Mailig, Mazen Almasry, et al.
Pageof 2